Veru CEO says cancer drug has potential to prevent Covid-19 deaths

Veru CEO Dr. Mitchell Steiner explained how VERU-111, a prostate cancer drug developed by the biotech company, could be used as an anti-inflammatory and antiviral treatment to help patients diagnosed with the novel coronavirus.
Mon, Feb 8 20217:23 PM EST